1. Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J.: Generalized anxiety and depression in primary care: prevalence, recognition, and management. The Journal of Clinical Psychiatry 63 Suppl 8:24–34, 2002.
2. Zou C, Ding X, Flaherty JH, Dong B.: Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients. Neuropsychiatric Disease and Treatment 9:1661–70, 2013. doi: 10.2147/NDT.S38899 .
3. Gerard A, Liard F, Crochard A, Goni S, Millet B.: Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment. Neuropsychiatric Disease and Treatment 8:605–14, 2012. doi: 10.2147/NDT.S34132 .
4. Kittirattanapaiboon P, Suttajit S, Junsirimongkol B, Likhitsathian S, Srisurapanont M.: Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders. Neuropsychiatric Disease and Treatment 10:453–8, 2014. doi: 10.2147/NDT.S56441 .
5. Yuce M, Zoroglu SS, Ceylan MF, Kandemir H, Karabekiroglu K.: Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: A study from Turkey. Neuropsychiatric Disease and Treatment 9:1791–9, 2013. doi: 10.2147/NDT.S54283 .